The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Honoraria - BeiGene
Updated analysis from a phase 2 study of tislelizumab (TIS) monotherapy in patients (pts) with previously treated, locally advanced, unresectable/metastatic microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) solid tumors.
 
Jian Li
No Relationships to Disclose
 
Ye Xu
No Relationships to Disclose
 
Aimin Zang
No Relationships to Disclose
 
Yunong Gao
No Relationships to Disclose
 
Quanli Gao
No Relationships to Disclose
 
Yanqiao Zhang
No Relationships to Disclose
 
Dong Wang
No Relationships to Disclose
 
Jianming Xu
No Relationships to Disclose
 
Ying Yuan
No Relationships to Disclose
 
Haiping Jiang
No Relationships to Disclose
 
Jieer Ying
No Relationships to Disclose
 
Chunmei Shi
No Relationships to Disclose
 
Yanhong Deng
No Relationships to Disclose
 
Jing Wang
No Relationships to Disclose
 
Tianshu Liu
No Relationships to Disclose
 
Yi Huang
No Relationships to Disclose
 
Yaling Xu
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Yidi Wang
Employment - BeiGene Shanghai
 
Cong Fei
No Relationships to Disclose
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squib; Daiichi Sankyo; Harbour BioMed; Merck; Mingji biopharmaceutical; MSD; Roche
Speakers' Bureau - Hutchison Whampoa; MSD
Research Funding - Baiji Shenzhou (Beijing) Biotechnology (Inst); Beijing Xiantong Biomedical Technology (Inst); Nanjing Yaojieankang Biotechnology (Inst); QiLu Pharmaceutical (Inst); Zaiding Pharmaceutical (Inst)